Pharmacology for Nurses · Cardiac Emergency and Shock Drugs
Cardiac Emergency Drugs
On this page 9 sections
In 30 seconds
Cardiac emergency drugs are the medications used while a person's heart is failing to maintain life-sustaining circulation — during cardiac arrest, severe bradycardia, or unstable, life-threatening dysrhythmias. The key is remembering what the heart needs in an emergency: an electrical rhythm that generates an adequate heartbeat, enough pressure to push blood to the brain and heart muscle (perfusion), and — for some rhythms — a shock to reset the electrical system. Different drug classes attack different links in that chain, so the first question for any cardiac emergency drug is: what problem is it aimed at — rhythm, pump strength, heart rate, or blood vessel tone?
None of these drugs works alone. They are given with high-quality CPR, Defibrillation A controlled electric shock that resets the heart's electrical activity Full entry → when indicated, and rapid identification of the underlying cause — drugs do not replace shocks or compressions. Because cardiac arrest care follows national algorithms that are periodically updated, the specific drug, order of administration, and dose always come from current guidelines and the prescriber's orders, not from memory of a static list.
Why this matters
Cardiac emergencies are the most time-critical events a nurse will face, and these drugs act within seconds to minutes. Understanding why a drug is given lets the nurse predict what to watch for: a drug that constricts blood vessels should raise blood pressure but may increase the heart's workload; a drug that slows conduction should calm a racing rhythm but can lower blood pressure if it overshoots. During a code, the nurse prepares, verifies, labels, and documents every medication, often from memory of the algorithm while the team leader directs. Knowing the drug classes and their mechanisms makes that role safer and faster — and it is exactly what exams test: given a rhythm or a problem, which drug class fits, and what does the nurse monitor afterward? Cardiac emergency drugs also illustrate the chapter's larger theme: emergency drugs buy time by supporting perfusion while the team finds and treats the underlying cause.
The college version
Core Concepts
The electrical problem: rhythm and rate
The heart's rhythm depends on electrical impulses that begin in the sinoatrial node, travel through the atria, pause at the atrioventricular node, and spread through the ventricles. When that system fails, the heart can beat too slowly (bradycardia), too fast or chaotically, or not at all. Antidysrhythmic drugs (Chapter 17) act by altering ion movement — sodium, potassium, and calcium — across the cardiac cell membrane. In the emergency setting, two stand out:
- Amiodarone is a Class III antidysrhythmic that primarily blocks potassium channels, prolonging repolarization and lengthening the Refractory period The brief time after a cardiac cell fires when it cannot fire again Full entry →, so abnormal circuits cannot re-excite the heart as easily. It also has sodium-channel, beta-blocking, and calcium-channel-blocking properties, making it broad-spectrum for serious ventricular dysrhythmias. Because it can lower blood pressure and slow the heart, its use is reserved for unstable situations and guided by current algorithms.
- Lidocaine is a Class IB sodium-channel blocker that suppresses abnormal automaticity in ventricular tissue — it targets ventricular ectopy and ventricular dysrhythmias, especially ischemic ones. It has little effect on the atria.
For symptomatic bradycardia, the emergency drug is atropine, an Anticholinergic A drug that blocks the parasympathetic (vagal) brake on the heart Full entry → that blocks the vagus nerve's braking effect on the heart, letting the sinoatrial node fire faster.
The pump problem: epinephrine
When the heart cannot generate enough pressure, emergency drugs support perfusion. The central figure is epinephrine, a nonselective Adrenergic agonist A drug that stimulates receptors activated by epinephrine/norepinephrine Full entry →. Its two relevant actions are alpha-1 stimulation (constricting vessels, which raises blood pressure and redirects blood to the heart and brain during CPR) and beta-1 stimulation (increasing heart rate and the force of contraction). That combination — raise the pressure, strengthen the pump — is why epinephrine is the mainstay vasopressor in cardiac arrest algorithms. The trade-off is predictable: stronger alpha stimulation raises pressure but also increases myocardial oxygen demand, so the drug is used only while the rhythm problem is being actively managed.
The shockable rhythm: defibrillation and drugs work together
For ventricular fibrillation and pulseless ventricular tachycardia, the definitive treatment is defibrillation — a controlled shock that depolarizes the entire myocardium at once, letting the heart's own pacemaker cells re-establish a coordinated rhythm. Drugs do not convert these rhythms; they make the heart more likely to respond to the next shock and to stay in a perfusing rhythm afterward. This is the single most important point: in a shockable arrest, the priority is shock → CPR → drug → shock, with the drug an adjunct to electrical therapy, never a substitute.
Supporting drugs: calcium, magnesium, and "treat the cause"
Some cardiac emergency drugs treat the cause rather than the rhythm:
- Calcium is given when dangerously high potassium (Hyperkalemia Dangerously high potassium in the blood Full entry →) or calcium-channel-blocker toxicity is suspected, because calcium opposes their effects on the cardiac cell membrane — a stabilizing measure while the underlying problem is corrected.
- Magnesium is the drug of choice for Torsades de pointes A fast, twisting ventricular dysrhythmia linked to a prolonged QT interval Full entry →, a distinctive polymorphic ventricular tachycardia linked to a prolonged QT interval; it stabilizes the cell electrically even when the serum level is not clearly low.
- Sodium bicarbonate may be considered in specific situations with severe metabolic acidosis, but current guidelines emphasize treating the cause (restoring perfusion and ventilation) rather than giving bicarbonate routinely.
The recurring principle: every cardiac emergency drug buys time while the team identifies and fixes the cause — ischemia, electrolyte disturbance, drug toxicity, hypoxia, or hypovolemia.
The nurse's role during a cardiac emergency
During a code, nursing actions follow the facility's protocol and the team leader's orders, but the pattern is consistent: recognize the emergency and call for help; start high-quality CPR and attach the monitor/defibrillator; prepare medications rapidly, verifying the right drug against the order and the current algorithm; document the time and dose of every medication; and monitor the person's response between rhythm checks. After the event, the nurse's work shifts to post-resuscitation care — continued monitoring, family support, and the debrief. Scope note: nurses prepare and administer emergency medications under orders and within their state's scope of practice and institutional policy; medication selection, doses, and algorithms vary by guideline version and facility, so everything here is class- and mechanism-level education — always verify against current references, the formulary, and prescriber orders.
Common Confusions
| Do Not Confuse | With | Difference |
|---|---|---|
| Giving a drug during a shockable arrest | Defibrillation | Drugs do not convert VF/pulseless VT; shocks do. Drugs support the rhythm between shocks |
| Amiodarone | Lidocaine | Amiodarone is broad-spectrum (Class III, plus other effects); lidocaine is a sodium-channel blocker aimed at ventricular ectopy, especially ischemic |
| Atropine for bradycardia | Atropine for arrest | Atropine is for symptomatic bradycardia, not for shockable or pulseless rhythms |
| Magnesium for torsades | Magnesium for "low magnesium" generally | Torsades gets magnesium even with a normal serum level — it stabilizes the cell membrane |
| "Memorizing the code algorithm" | Understanding the mechanisms | Algorithms change and doses are ordered; mechanisms transfer across guideline versions |
| Epinephrine "working well" | Epinephrine being risk-free | Its alpha/beta effects raise pressure and contractility but also increase myocardial oxygen demand |

Eli explains
The same idea, in plain words
Explain it like I’m 10
Imagine the heart is a pump with an electrical battery. When the wiring goes haywire, the pump quivers instead of pushing blood, so the emergency team uses a big shock to reset the wiring. The medications are helpers that steady the wiring (antiarrhythmics), speed up a too-slow pump (atropine), or squeeze the pipes so blood keeps reaching the brain and heart (epinephrine) — but none works unless someone is also doing chest compressions. The drugs and the shock work as a team.
Worked example
A person on the cardiac unit suddenly loses consciousness, and the monitor shows ventricular fibrillation. The nurse calls a code, starts chest compressions, and the team applies the defibrillator pads; the person is defibrillated. The rhythm remains ventricular fibrillation, so the team leader orders epinephrine, and the nurse — code cart open, medication drawn up per the algorithm — verifies the order, administers it, and documents the time. CPR continues, and the leader orders amiodarone as the antiarrhythmic adjunct before the next shock. Throughout, the nurse's mental model runs the chain: compressions keep blood moving, epinephrine keeps pressure up so blood reaches the brain and heart, amiodarone makes the next shock more likely to work, and the shock is the therapy that actually converts the rhythm. When the rhythm converts, the nurse's attention shifts to monitoring blood pressure, rhythm, and mentation — the same mechanism knowledge now applied to watching for the drug's effects in the post-resuscitation period.
Key takeaways
- Cardiac emergency drugs support rhythm, rate, pump strength, or vessel tone — identify which problem each drug addresses.
- Epinephrine is the mainstay vasopressor in cardiac arrest: alpha-1 raises blood pressure; beta-1 increases rate and contractility. It increases myocardial oxygen demand — a predictable trade-off.
- Amiodarone (Class III, potassium-channel blockade, broad-spectrum) treats serious ventricular dysrhythmias; it can lower blood pressure and slow the heart.
- Lidocaine (Class IB, sodium-channel blockade) targets ventricular ectopy, especially ischemic; it does not treat atrial rhythms.
- Atropine (anticholinergic) treats symptomatic bradycardia by removing vagal braking on the sinoatrial node.
- Defibrillation converts shockable rhythms (VF, pulseless VT); drugs make the heart more responsive to shocks — they do not replace them.
- Magnesium treats torsades de pointes; calcium treats hyperkalemia and calcium-channel-blocker toxicity — both "stabilize the membrane while you find the cause."
- Algorithms change: drugs, order, and doses follow current guidelines and prescriber orders — always verify against current references, the formulary, and facility protocol.
Check yourself
5 review questions from the chapter. Try each one, then open the answer.
Why is defibrillation the definitive treatment for ventricular fibrillation, with drugs in a supporting role?
Show answer
Defibrillation depolarizes the whole myocardium at once so the heart's own pacemaker cells can restart a coordinated rhythm. Drugs (like amiodarone) make the myocardium more likely to convert and stay converted, but they cannot reliably convert the rhythm themselves.
Epinephrine has two relevant receptor actions in cardiac arrest. What does each do, and what is the trade-off?
Show answer
Alpha-1 stimulation constricts vessels, raising blood pressure and directing blood to the heart and brain during CPR; beta-1 stimulation increases heart rate and contractility. The trade-off is increased myocardial oxygen demand.
A person is in pulseless ventricular tachycardia that keeps returning after shocks. Which two drug mechanisms might the team use?
Show answer
A broad-spectrum antiarrhythmic such as amiodarone (prolongs repolarization/refractory period, suppressing re-entry) and/or lidocaine (sodium-channel blockade suppressing ventricular ectopy). Both support the rhythm so the next shock can convert it.
How does atropine raise a dangerously slow heart rate?
Show answer
Atropine blocks the vagus nerve's parasympathetic braking on the sinoatrial node, allowing the node to fire faster and the heart rate to rise.
Why would a team give magnesium to a person whose serum magnesium is not low?
Show answer
In torsades de pointes, magnesium stabilizes the cardiac cell membrane electrically even when serum levels are normal — the drug treats the rhythm problem, not a measured deficiency.
Study toolsKey vocabulary
Key vocabulary
- Defibrillation
- A controlled electric shock that resets the heart's electrical activity
- Adrenergic agonist
- A drug that stimulates receptors activated by epinephrine/norepinephrine
- Refractory period
- The brief time after a cardiac cell fires when it cannot fire again
- Anticholinergic
- A drug that blocks the parasympathetic (vagal) brake on the heart
- Torsades de pointes
- A fast, twisting ventricular dysrhythmia linked to a prolonged QT interval
- Hyperkalemia
- Dangerously high potassium in the blood
Sources & references
This lesson was adapted from the open educational references above; their licenses and attributions are preserved. See Copyright & Licensing.
Educational content only. It is not medical, legal or professional advice. Found an error? Tell us.

